WALTHAM, Mass.–(BUSINESS WIRE)–Regenerative medicine company Histogenics Corporation appoints Michael Lewis, M.D. to CMO and Peter Hamilton to VP of Manufacturing & Production to support Phase 3 development of NeoCart.
Home » Histogenics hires Dr. Michael Lewis and Peter Hamiltion to lead NeoCart in Phase III